Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Viet Nam in new human avian flu alert:

This article was originally published in Clinica

Executive Summary

Viet Nam is investigating a single human case of avian flu (H5N1) infection, the first since early September 2004, when a spate of cases raised fears of human-to-human transmission (see Clinica No 1126, p 13). "As avian influenza viruses become more active at cooler temperatures, further poultry outbreaks, possibly accompanied by sporadic human cases, can be anticipated," said the World Health Organization (WHO), in response to the "informal reports of a laboratory-confirmed case" in the southern province of Tay Ninh. The latest case, reported on December 30, brings the total number of human cases in Viet Nam in 2004 to 28, of which 20 were fatal. Reports of human cases in Thailand brought the 2004 total in Asia to 45, including 32 fatalities.

You may also be interested in...



Neuroscience Challenges Oncology For Top Spot In CDER’s 2019 Novel Approvals

Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.

In Case You Missed It … News On China Patents, EMA Chief, And More

We clean out your Martin Luther King Day inbox so you don't have to.

At Muted J.P. Morgan, Focus Is Execution, But US Pricing Is Persistent Overhang

Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.

Topics

UsernamePublicRestriction

Register

MT053921

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel